Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-04-20Clinical Trial Update: Comparison of Indacaterol With That of Placebo in 'Maintenance naïve' Patients With COPD Using Blinded Tiotropium as Active Control [Phase 4]
A Phase 4 trial evaluating indacaterol versus placebo in maintenance-naïve patients with chronic obstructive pulmonary disease, using blinde…
-
CLINICAL_TRIALS withdrawal · 2017-04-20Clinical Trial Update: Efficacy of Indacaterol 150 µg Versus Formoterol [Phase 4]
A Phase 4 clinical trial comparing indacaterol 150 µg versus formoterol for chronic obstructive pulmonary disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-20Clinical Trial Update: Study to Evaluate the Impact of the "PROactive Telecoaching Program" on Physical Activity in Patients With COPD. [Phase 4]
A Phase 4 clinical trial evaluating a telecoaching program to boost physical activity in patients with chronic obstructive pulmonary disease…
-
CLINICAL_TRIALS withdrawal · 2017-04-20Clinical Trial Update: Safety and Efficacy of NVA237 as an add-on to Fixed Dose Combination LABA/ICS [Phase 3]
Phase 3 trial evaluating NVA237 (umeclidinium) as an add-on to fixed-dose LABA/ICS for COPD has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-11Clinical Trial Update: Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD [Phase 2]
A Phase 2 trial of inhaled treprostinil for adult pulmonary hypertension due to chronic obstructive pulmonary disease has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-04-11Clinical Trial Update: ICE COPD PikoLogic® Cohort Study.Implementation, Compliance, and Effectiveness of Integrating the PikoLogic®
Withdrawn: The ICE COPD PikoLogic Cohort Study evaluating implementation, compliance, and effectiveness of integrating PikoLogic for COPD ha…
-
CLINICAL_TRIALS withdrawal · 2017-04-10Clinical Trial Update: Study of the Effect on Clinical Outcomes Using Secure Text Messaging [NA]
The University of Pennsylvania-sponsored trial NCT02568514 evaluating the effect of secure text messaging on clinical outcomes has been with…
-
CLINICAL_TRIALS withdrawal · 2017-03-29Clinical Trial Update: Escitalopram in Anxiety Associated Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [Phase 3]
A Phase 3 trial evaluating escitalopram for anxiety in COPD exacerbations has been withdrawn. No results were reported.
-
CLINICAL_TRIALS withdrawal · 2017-03-29Clinical Trial Update: Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE Levels [Phase 2]
A Phase 2 exploratory study of omalizumab (Xolair) in chronic obstructive pulmonary disease patients with elevated IgE levels has been withd…
-
CLINICAL_TRIALS withdrawal · 2017-03-22Clinical Trial Update: Home Mechanical Ventilation in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Hypercapnic Response [NA]
A clinical trial investigating home mechanical ventilation in patients with chronic obstructive pulmonary disease and hypercapnic response h…
-
CLINICAL_TRIALS withdrawal · 2017-03-16Clinical Trial Update: Adipose Derived Cells for Chronic Obstructive Pulmonary Disease [NA]
A clinical trial evaluating adipose-derived cells for chronic obstructive pulmonary disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-02-15Clinical Trial Update: Efficacy and Safety Study of Formoterol/Fluticasone and Salmeterol/Fluticasone in Patients With Moderate-to-severe COPD [Phase 3]
A Phase 3 trial comparing Formoterol/Fluticasone and Salmeterol/Fluticasone for moderate-to-severe chronic obstructive pulmonary disease was…
-
EMA withdrawal · 2017-01-31EMA Withdrawn: Budesonide/Formoterol Teva (Budesonide;formoterol fumarate dihydrate) — Teva Pharma B.V.
EMA confirms withdrawal of Budesonide/Formoterol Teva, a combination inhaled therapy, from the product market.
-
EMA withdrawal · 2017-01-26EMA Withdrawn: Vylaer Spiromax (Budesonide;formoterol fumarate dihydrate) — Teva Pharma B.V.
The EMA has withdrawn Vylaer Spiromax (budesonide/formoterol) from the market in the EU.
-
CLINICAL_TRIALS withdrawal · 2017-01-16Clinical Trial Update: A Novel Unidirectional Face Mask During NPPV in COPD Patients [NA]
A clinical trial evaluating a novel unidirectional face mask during noninvasive positive pressure ventilation in COPD patients has been with…
-
CLINICAL_TRIALS withdrawal · 2017-01-12Clinical Trial Update: Cardiac Hemodynamics in Overlap Syndrome (COPD With Obstructive Sleep Apnea) [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating cardiac hemodynamics in overlap syndrome (COPD with obstructive sleep apnea) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-11-15Clinical Trial Update: Mucin Concentration in Sputum From COPD Patients During a Pulmonary Exacerbation
This clinical trial investigating mucin concentration in sputum from COPD patients during a pulmonary exacerbation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-27Clinical Trial Update: A Multi-center Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of R7103 Following Repeated Inhalation in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease [Phase 1]
A Phase 1, multi-center inhalation study of R7103 in patients with COPD was withdrawn from the trial program; the study examined safety, tol…
-
CLINICAL_TRIALS withdrawal · 2016-09-30Clinical Trial Update: Smog Induced Indoor Air Pollution in Homes of Chronic Obstructive Pulmonary Disease Patients.
This clinical trial investigating smog-induced indoor air pollution in homes of COPD patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-09-28Clinical Trial Update: A Pilot Safety Study of Inhaled Dry Powder Mannitol in Acute Exacerbations of COPD [Phase 1, Phase 2]
A pilot safety study evaluating inhaled dry powder mannitol for acute exacerbations of chronic obstructive pulmonary disease has been withdr…
-
CLINICAL_TRIALS withdrawal · 2016-08-26Clinical Trial Update: Telemedical Training for Chronically Ill COPD Patients: a Cross Sectoral Study [NA]
A clinical trial evaluating telemedical training for patients with chronic obstructive pulmonary disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-08-22Clinical Trial Update: Efficacy of NVA237 (50 μg o.d) Using Tiotropium (5μg μg o.d) as Active Control in COPD Patients. [Phase 3]
A Phase 3 trial evaluating NVA237 (umeclidinium) at 50 μg once daily with tiotropium as an active control in COPD patients was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-08-04Clinical Trial Update: Perforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT) [Phase 4]
A Phase 4 trial comparing Perforomist to Foradil in COPD patients, evaluated by inspiratory capacity and high-resolution CT, has been withdr…
-
CLINICAL_TRIALS withdrawal · 2016-07-22Clinical Trial Update: A Study Comparing the Closed Triple Therapy, Open Triple Therapy and a Dual Therapy for Effect on Lung Function in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 COPD trial comparing closed triple therapy, open triple therapy, and dual therapy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-07-19Clinical Trial Update: EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients
A clinical trial evaluating the EarlySense monitoring device in patients with COPD, congestive heart failure, and pneumonia has been withdra…